{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:06:34Z","timestamp":1783598794317,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010226","name":"Department of Education of Guangdong Province","doi-asserted-by":"publisher","award":["2017KQNCX068"],"award-info":[{"award-number":["2017KQNCX068"]}],"id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Measuring the DNA methylome may offer the opportunity to identify novel disease biomarkers and insights into disease mechanisms. Although aberrant DNA methylation has been investigated in many human cancers and precancerous lesions, the DNA methylation landscape of gastric cardiac intestinal metaplasia (IM) remains unknown. Therefore, we aimed to investigate the genome-wide DNA methylation landscape and to search for potential epigenetic biomarkers of gastric cardiac IM.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Histopathologic profiling was performed on a total of 118 gastric cardiac biopsies from cancer-free individuals. Genome-wide DNA methylation analysis was performed on 11 gastric cardiac mucosal biopsies (IM\u2009=\u20097; normal\u2009=\u20094) using Illumina 850K microarrays. Transcriptional relevance of any candidate epigenetic biomarker was validated by qRT-PCR.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The detection rate of gastric cardiac IM was 23% (27\/118) in cancer-free individuals. Genome-wide DNA methylation profiling showed a global decrease in methylation in IM compared with normal tissues (median methylation\u2009=\u20090.64 and 0.70 for gastric cardiac IM and normal tissues, respectively). Differential methylation analysis between gastric cardiac IM and normal tissues identified 38,237 differentially methylated probes (DMPs) with a majority of sites showing hypermethylation in IM compared with normal tissues (56.3% vs. 43.7%). Subsequent analysis revealed a significant enrichment of hypermethylated DMPs in promoter and CpG islands (<jats:italic>p\u2009<\/jats:italic>&lt;\u20090.001 for both, Pearson <jats:italic>\u03c7<\/jats:italic><jats:sup>2<\/jats:sup> test). For DMPs located in promoter CpG islands showing extreme hypermethylation, the candidate gene with the largest number of DMPs (<jats:italic>n<\/jats:italic>\u2009=\u20097) was mapped to <jats:italic>HOXA5<\/jats:italic>. Accordingly, mRNA expression of HOXA5 was significantly reduced in IM compared to normal tissue.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Our results suggest the implication of alterations in DNA methylation in gastric cardiac IM and highlight that <jats:italic>HOXA5<\/jats:italic> hypermethylation may be a promising epigenetic biomarker, emphasizing the role of aberrant HOXA5 expression in the pathogenesis of gastric cardiac IM.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12967-020-02453-2","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T08:07:14Z","timestamp":1596182834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Genome-wide DNA methylation profiling identifies epigenetic signatures of gastric cardiac intestinal metaplasia"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7014-9829","authenticated-orcid":false,"given":"Runhua","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruinuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"2453_CR1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1053\/j.gastro.2008.01.071","volume":"134","author":"AC de Vries","year":"2008","unstructured":"de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, Kuipers EJ. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134:945\u201352.","journal-title":"Gastroenterology"},{"issue":"7","key":"2453_CR2","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/ijc.31571","volume":"143","author":"L Shao","year":"2018","unstructured":"Shao L, Li P, Ye J, Chen J, Han Y, Cai J, Lu X. Risk of gastric cancer among patients with gastric intestinal metaplasia. Int J Cancer. 2018;143(7):1671\u20137.","journal-title":"Int J Cancer"},{"key":"2453_CR3","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","volume":"365","author":"F Hvid-Jensen","year":"2011","unstructured":"Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett\u2019s esophagus. N Engl J Med. 2011;365:1375\u201383.","journal-title":"N Engl J Med"},{"key":"2453_CR4","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1056\/NEJMra023075","volume":"349","author":"JG Herman","year":"2003","unstructured":"Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003;349:2042\u201354.","journal-title":"N Engl J Med"},{"key":"2453_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13148-019-0695-0","volume":"11","author":"AF Vega-Benedetti","year":"2019","unstructured":"Vega-Benedetti AF, Loi E, Moi L, Blois S, Fadda A, Antonelli M, Arcella A, Badiali M, Giangaspero F, Morra I, et al. Clustered protocadherins methylation alterations in cancer. Clin Epigenetics. 2019;11:100.","journal-title":"Clin Epigenetics"},{"issue":"9","key":"2453_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","volume":"16","author":"WM Linehan","year":"2019","unstructured":"Linehan WM, Ricketts CJ. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications. Nat Rev Urol. 2019;16(9):539\u201352.","journal-title":"Nat Rev Urol"},{"key":"2453_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2217\/epi.15.4","volume":"7","author":"T Tahara","year":"2015","unstructured":"Tahara T, Arisawa T. DNA methylation as a molecular biomarker in gastric cancer. Epigenomics. 2015;7:475\u201386.","journal-title":"Epigenomics"},{"issue":"6","key":"2453_CR8","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s10120-019-00949-5","volume":"22","author":"K Sugimoto","year":"2019","unstructured":"Sugimoto K, Ito T, Hulbert A, Chen C, Orita H, Maeda M, Moro H, Fukagawa T, Ushijima T, Katai H, et al. DNA methylation genome-wide analysis in remnant and primary gastric cancers. Gastric Cancer. 2019;22(6):1109\u201320.","journal-title":"Gastric Cancer"},{"issue":"137\u2013150","key":"2453_CR9","first-page":"e135","volume":"33","author":"KK Huang","year":"2018","unstructured":"Huang KK, Ramnarayanan K, Zhu F, Srivastava S, Xu C, Tan ALK, Lee M, Tay S, Das K, Xing M, et al. Genomic and epigenomic profiling of high-risk intestinal metaplasia reveals molecular determinants of progression to gastric cancer. Cancer Cell. 2018;33(137\u2013150):e135.","journal-title":"Cancer Cell"},{"key":"2453_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00428-016-1948-3","volume":"469","author":"T Tahara","year":"2016","unstructured":"Tahara T, Shibata T, Kawamura T, Horiguchi N, Okubo M, Nakano N, Ishizuka T, Nagasaka M, Nakagawa Y, Ohmiya N. Telomere length shortening in gastric mucosa is a field effect associated with increased risk of gastric cancer. Virchows Arch. 2016;469:19\u201324.","journal-title":"Virchows Arch"},{"key":"2453_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/bioinformatics\/btt684","volume":"30","author":"TJ Morris","year":"2014","unstructured":"Morris TJ, Butcher LM, Feber A, Teschendorff AE, Chakravarthy AR, Wojdacz TK, Beck S. ChAMP: 450k chip analysis methylation pipeline. Bioinformatics. 2014;30:428\u201330.","journal-title":"Bioinformatics"},{"key":"2453_CR12","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA. Minfi: a flexible and comprehensive bioconductor package for the analysis of infinium DNA methylation microarrays. Bioinformatics. 2014;30:1363\u20139.","journal-title":"Bioinformatics"},{"key":"2453_CR13","doi-asserted-by":"publisher","first-page":"R44","DOI":"10.1186\/gb-2012-13-6-r44","volume":"13","author":"J Maksimovic","year":"2012","unstructured":"Maksimovic J, Gordon L, Oshlack A. SWAN: subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome Biol. 2012;13:R44.","journal-title":"Genome Biol"},{"key":"2453_CR14","first-page":"e22","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 2017;45:e22.","journal-title":"Nucleic Acids Res"},{"key":"2453_CR15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/1471-2105-11-587","volume":"11","author":"P Du","year":"2010","unstructured":"Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, Lin SM. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinf. 2010;11:587.","journal-title":"BMC Bioinf"},{"key":"2453_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:3.","journal-title":"Stat Appl Genet Mol Biol"},{"key":"2453_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/2045-3701-4-45","volume":"4","author":"E Baxter","year":"2014","unstructured":"Baxter E, Windloch K, Gannon F, Lee JS. Epigenetic regulation in cancer progression. Cell Biosci. 2014;4:45.","journal-title":"Cell Biosci"},{"key":"2453_CR18","first-page":"1317","volume":"40","author":"X Peng","year":"2018","unstructured":"Peng X, Zha L, Chen A, Wang Z. HOXA5 is a tumor suppressor gene that is decreased in gastric cancer. Oncol Rep. 2018;40:1317\u201329.","journal-title":"Oncol Rep"},{"key":"2453_CR19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1242\/bio.20121701","volume":"1","author":"O Boucherat","year":"2012","unstructured":"Boucherat O, Chakir J, Jeannotte L. The loss of Hoxa5 function promotes Notch-dependent goblet cell metaplasia in lung airways. Biol Open. 2012;1:677\u201391.","journal-title":"Biol Open"},{"key":"2453_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jhep.2019.03.007","volume":"71","author":"J Bayo","year":"2019","unstructured":"Bayo J, Fiore EJ, Dominguez LM, Real A, Malvicini M, Rizzo M, Atorrasagasti C, Garcia MG, Argemi J, Martinez ED, Mazzolini GD. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets. J Hepatol. 2019;71:78\u201390.","journal-title":"J Hepatol"},{"key":"2453_CR21","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1158\/1078-0432.CCR-15-2346","volume":"22","author":"A Diaz-Lagares","year":"2016","unstructured":"Diaz-Lagares A, Mendez-Gonzalez J, Hervas D, Saigi M, Pajares MJ, Garcia D, Crujerias AB, Pio R, Montuenga LM, Zulueta J, et al. A novel epigenetic signature for early diagnosis in lung cancer. Clin Cancer Res. 2016;22:3361\u201371.","journal-title":"Clin Cancer Res"},{"key":"2453_CR22","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1158\/1078-0432.CCR-13-2109","volume":"20","author":"J Wrangle","year":"2014","unstructured":"Wrangle J, Machida EO, Danilova L, Hulbert A, Franco N, Zhang W, Glockner SC, Tessema M, Van Neste L, Easwaran H, et al. Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer. Clin Cancer Res. 2014;20:1856\u201364.","journal-title":"Clin Cancer Res"},{"key":"2453_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1586\/erm.12.45","volume":"12","author":"T Mikeska","year":"2012","unstructured":"Mikeska T, Bock C, Do H, Dobrovic A. DNA methylation biomarkers in cancer: progress towards clinical implementation. Expert Rev Mol Diagn. 2012;12:473\u201387.","journal-title":"Expert Rev Mol Diagn"},{"key":"2453_CR24","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.4161\/epi.6.12.18199","volume":"6","author":"AM Kaz","year":"2011","unstructured":"Kaz AM, Wong CJ, Luo Y, Virgin JB, Washington MK, Willis JE, Leidner RS, Chak A, Grady WM. DNA methylation profiling in Barrett\u2019s esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses. Epigenetics. 2011;6:1403\u201312.","journal-title":"Epigenetics"},{"issue":"418\u2013429","key":"2453_CR25","doi-asserted-by":"publisher","first-page":"e418","DOI":"10.1053\/j.gastro.2014.04.039","volume":"147","author":"Y Luo","year":"2014","unstructured":"Luo Y, Wong CJ, Kaz AM, Dzieciatkowski S, Carter KT, Morris SM, Wang J, Willis JE, Makar KW, Ulrich CM, et al. Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014;147(418\u2013429):e418.","journal-title":"Gastroenterology"},{"key":"2453_CR26","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1158\/1055-9965.EPI-15-0370","volume":"24","author":"M Yu","year":"2015","unstructured":"Yu M, O\u2019Leary RM, Kaz AM, Morris SM, Carter KT, Chak A, Chandar A, Willis JE, Moinova HR, Markowitz SD, et al. Methylated B3GAT2 and ZNF793 are potential detection biomarkers for Barrett\u2019s esophagus. Cancer Epidemiol Biomarkers Prev. 2015;24:1890\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"956\u2013966","key":"2453_CR27","first-page":"e954","volume":"144","author":"W Wu","year":"2013","unstructured":"Wu W, Bhagat TD, Yang X, Song JH, Cheng Y, Agarwal R, Abraham JM, Ibrahim S, Bartenstein M, Hussain Z, et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett\u2019s esophagus and esophageal adenocarcinoma. Gastroenterology. 2013;144(956\u2013966):e954.","journal-title":"Gastroenterology"},{"key":"2453_CR28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2217\/epi-2016-0044","volume":"8","author":"V Vymetalkova","year":"2016","unstructured":"Vymetalkova V, Vodicka P, Pardini B, Rosa F, Levy M, Schneiderova M, Liska V, Vodickova L, Nilsson TK, Farkas SA. Epigenome-wide analysis of DNA methylation reveals a rectal cancer-specific epigenomic signature. Epigenomics. 2016;8:1193\u2013207.","journal-title":"Epigenomics"},{"key":"2453_CR29","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1093\/carcin\/bgt286","volume":"34","author":"E Xu","year":"2013","unstructured":"Xu E, Gu J, Hawk ET, Wang KK, Lai M, Huang M, Ajani J, Wu X. Genome-wide methylation analysis shows similar patterns in Barrett\u2019s esophagus and esophageal adenocarcinoma. Carcinogenesis. 2013;34:2750\u20136.","journal-title":"Carcinogenesis"},{"key":"2453_CR30","doi-asserted-by":"publisher","first-page":"L817","DOI":"10.1152\/ajplung.00006.2013","volume":"304","author":"O Boucherat","year":"2013","unstructured":"Boucherat O, Montaron S, Berube-Simard FA, Aubin J, Philippidou P, Wellik DM, Dasen JS, Jeannotte L. Partial functional redundancy between Hoxa5 and Hoxb5 paralog genes during lung morphogenesis. Am J Physiol Lung Cell Mol Physiol. 2013;304:L817\u201330.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2453_CR31","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nature01972","volume":"425","author":"DM Berman","year":"2003","unstructured":"Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, Beachy PA. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature. 2003;425:846\u201351.","journal-title":"Nature"},{"key":"2453_CR32","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2015.11.001","volume":"28","author":"P Ordonez-Moran","year":"2015","unstructured":"Ordonez-Moran P, Dafflon C, Imajo M, Nishida E, Huelsken J. HOXA5 counteracts stem cell traits by inhibiting Wnt signaling in colorectal cancer. Cancer Cell. 2015;28:815\u201329.","journal-title":"Cancer Cell"},{"key":"2453_CR33","doi-asserted-by":"publisher","first-page":"8007","DOI":"10.1158\/0008-5472.CAN-07-1405","volume":"67","author":"H Chen","year":"2007","unstructured":"Chen H, Zhang H, Lee J, Liang X, Wu X, Zhu T, Lo PK, Zhang X, Sukumar S. HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition. Cancer Res. 2007;67:8007\u201313.","journal-title":"Cancer Res"},{"key":"2453_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/carcin\/bgl133","volume":"28","author":"G Strathdee","year":"2007","unstructured":"Strathdee G, Sim A, Soutar R, Holyoake TL, Brown R. HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia. Carcinogenesis. 2007;28:299\u2013309.","journal-title":"Carcinogenesis"},{"key":"2453_CR35","doi-asserted-by":"publisher","first-page":"35807","DOI":"10.1038\/srep35807","volume":"6","author":"I Daugaard","year":"2016","unstructured":"Daugaard I, Dominguez D, Kjeldsen TE, Kristensen LS, Hager H, Wojdacz TK, Hansen LL. Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma. Sci Rep. 2016;6:35807.","journal-title":"Sci Rep"},{"key":"2453_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-230X-14-55","volume":"14","author":"M Loh","year":"2014","unstructured":"Loh M, Liem N, Vaithilingam A, Lim PL, Sapari NS, Elahi E, Mok ZY, Cheng CL, Yan B, Pang B, et al. DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach. BMC Gastroenterol. 2014;14:55.","journal-title":"BMC Gastroenterol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02453-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-020-02453-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02453-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:10:58Z","timestamp":1627690258000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02453-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2453"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02453-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"assertion":[{"value":"2 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of Shantou University Medical College, and written, informed consent was obtained from all study participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"292"}}